Contact Us
(833) 486-3753

Category: Blog

2025 in Stories – What Mattered, What Changed, and What Comes Next

2025 wasn’t a quiet year. It was a year of breakthroughs, reawakening, and a reshaping of expectations across medicine, biotech, diagnostics, and how we talk about health, with implications that will echo well into 2026 and beyond. What 2025 Taught Us Technology finally started catching up to ambition. Across drug discovery, diagnostics, and personalized care, …

Misinformation, AI Hallucinations & The Communications Failures of 2025

2025 will go down as the year communication cracked under pressure. With health anxieties high and digital tools more accessible than ever, misinformation didn’t stay online; it seeped into exam rooms, treatment decisions, and patient minds. At the same time, the rapid embrace of generative AI promised to revolutionize medical education, content creation, and patient …

Women’s Health 2025: The Year We Finally Started Listening

Every December, we like to pause, not just to reflect on the year behind us, but to look squarely at the one ahead. 2025 brought seismic shifts across healthcare: scientific momentum accelerating faster than ever, communication standards evolving in real time, and long-overlooked areas finally stepping into the spotlight. So, to close out the year, …

The Evolution and Future of Biopsies: From Cutting Tissue to Decoding Data

Biopsies have long been the gold standard diagnostic tool in medicine, a trusted window into the body’s most guarded secrets. For more than a century, the formula has barely changed: take a piece of tissue, place it on a slide, stain it, and rely on a pathologist’s expert eye to decode what’s really happening inside. …

When Labels Change but Confusion Remains: Supporting Women Through HRT’s New Era

On November 10, 2025, the U.S. Food and Drug Administration announced it was removing the long-standing “black box” warning from many menopausal hormone replacement therapy (HRT) labels. For many women, that warning created fear and confusion about whether hormones are “too risky,” even when facing unmanageable symptoms.Menopausal HRT involves taking estrogen, with or without a …